Search Results

HERPUD1 promotes ovarian cancer cell survival by sustaining autophagy and inhibit apoptosis via PI3K/AKT/mTOR and p38 MAPK signaling pathways.

• Authors : Nie X; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, 36 Sanhao Road, Heping District, Shenyang, 110004, China.; Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Shenyang, China.

Subjects: Autophagy*/Autophagy*/Autophagy*/genetics ; Cell Survival*/Cell Survival*/Cell Survival*/genetics ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/genetics

• Source: BMC cancer [BMC Cancer] 2022 Dec 21; Vol. 22 (1), pp. 1338. Date of Electronic Publication: 2022 Dec 21.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth

• Authors : Sayani Bhattacharjee; Matthew J. Sullivan; Rebecca R. Wynn

Subjects: Male; 0301 basic medicine; Cell Survival

• Source: BMC CancerBMC Cancer, Vol 22, Iss 1, Pp 1-14 (2022)

Record details

Bag-1 stimulates Bad phosphorylation through activation of Akt and Raf kinases to mediate cell survival in breast cancer

• Authors : Tugba Kizilboga; Emine Arzu Baskale; Jale Yildiz

Subjects: 0301 basic medicine; Cell Survival; Apoptosis

• Source: BMC CancerBMC Cancer, Vol 19, Iss 1, Pp 1-13 (2019)

Record details

Astaxanthin-loaded PLGA nanoparticles inhibit survival of MKN-45 gastric cancer cell line by modulating JAK2/STAT3/mTOR/PI3K pathway.

• Authors : YektaKooshali MH; Medical Biotechnology Research Center, School of Paramedicine, Guilan University of Medical Sciences, Rasht, Iran.; Department of Cellular and Molecular Biology, Lahijan Branch, Islamic Azad University, Lahijan, Iran.

Subjects: Janus Kinase 2*/Janus Kinase 2*/Janus Kinase 2*/metabolism ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/drug therapy ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/metabolism

• Source: BMC cancer [BMC Cancer] 2025 Jan 09; Vol. 25 (1), pp. 44. Date of Electronic Publication: 2025 Jan 09.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Effect of short-term fasting on the cisplatin activity in human oral squamous cell carcinoma cell line HN5 and chemotherapy side effects.

• Authors : Sheykhbahaei N; Department of Oral Medicine, School of Dentistry, Tehran University of Medical Sciences, North Kargar St, Tehran, 14399-55991, Iran.; Tameemi AHA

Subjects: Cisplatin*/Cisplatin*/Cisplatin*/pharmacology ; Cisplatin*/Cisplatin*/Cisplatin*/adverse effects ; Keratinocytes*/Keratinocytes*/Keratinocytes*/drug effects

• Source: BMC cancer [BMC Cancer] 2024 Aug 09; Vol. 24 (1), pp. 989. Date of Electronic Publication: 2024 Aug 09.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling

• Authors : Ferreira, Luciana Bueno; Palumbo, Antonio; de Mello, Kivvi Duarte

• Source: BMC Cancer. 12(1)

Record details

Astragaloside IV inhibits cell viability and glycolysis of hepatocellular carcinoma by regulating KAT2A-mediated succinylation of PGAM1.

• Authors : Zhu Y; Department of Pharmacy, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Second Road, Huangpu District, Shanghai, 200020, China.; Lu F

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology

• Source: BMC cancer [BMC Cancer] 2024 Jun 04; Vol. 24 (1), pp. 682. Date of Electronic Publication: 2024 Jun 04.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-XL cell survival genes

• Authors : Paula Maciel-Silva; Izabela Caldeira; Icaro de Assis Santos

Subjects: Male; 0301 basic medicine; Cell Survival

• Source: BMC CancerBMC Cancer, Vol 18, Iss 1, Pp 1-15 (2018)

Record details

IL-1-conferred gene expression pattern in ERα+ BCa and AR+ PCa cells is intrinsic to ERα− BCa and AR− PCa cells and promotes cell survival

• Authors : Afshan F. Nawas; Mohammed Kanchwala; Shayna E. Thomas-Jardin

Subjects: Interleukin-1; Breast cancer; Prostate cancer

• Source: BMC Cancer, Vol 20, Iss 1, Pp 1-15 (2020)

Record details

MIR494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes

• Authors : Dutta, Punashi; Haller, Edward; Sharp, Arielle

Subjects: 0301 basic medicine; Cancer Research; Cell Survival

• Source: BMC Cancer

Record details